batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Agenus mulls a solo TIGIT path 5 August 2024 In Secura’s hands PI3K delta lives on 5 August 2024 FibroGen finally walks away from pamrevlumab 31 July 2024 Boehringer takes on AbbVie in a novel checkpoint 30 July 2024 Incyte swings the axe on oral checkpoint inhibitors 30 July 2024 Syndax hit by menin delay 29 July 2024 Argenx steps back from subcutaneous Vyvgart 26 July 2024 Novartis buys into Dren’s bispecifics 25 July 2024 Load More